BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21179270)

  • 1. The role of photodynamic therapy for hilar cholangiocarcinoma.
    Cheon YK
    Korean J Intern Med; 2010 Dec; 25(4):345-52. PubMed ID: 21179270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy for cholangiocarcinoma.
    Berr F
    Semin Liver Dis; 2004 May; 24(2):177-87. PubMed ID: 15192790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of photodynamic therapy for bile duct cancer.
    Lee TY; Cheon YK; Shim CS
    Clin Endosc; 2013 Jan; 46(1):38-44. PubMed ID: 23423177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy in cholangiocarcinoma.
    Kahaleh M
    J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S44-7. PubMed ID: 23055215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment of nonresectable cholangiocarcinoma complicated by obstructive jaundice.
    Shiryaev AA; Musaev GK; Levkin VV; Reshetov IV; Loshchenov MV; Alekseeva PM; Volkov VV; Linkov KG; Makarov VI; Shchekoturov IO; Borodkin AV; Loschenov VB
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():218-223. PubMed ID: 30965145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis.
    Moole H; Tathireddy H; Dharmapuri S; Moole V; Boddireddy R; Yedama P; Dharmapuri S; Uppu A; Bondalapati N; Duvvuri A
    World J Gastroenterol; 2017 Feb; 23(7):1278-1288. PubMed ID: 28275308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy for unresectable cholangiocarcinoma.
    Tomizawa Y; Tian J
    Dig Dis Sci; 2012 Feb; 57(2):274-83. PubMed ID: 22057285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy for non-resectable perihilar cholangiocarcinoma.
    Kiesslich T; Wolkersdörfer G; Neureiter D; Salmhofer H; Berr F
    Photochem Photobiol Sci; 2009 Jan; 8(1):23-30. PubMed ID: 19247524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technology insight: Photodynamic therapy for cholangiocarcinoma.
    Ortner MA; Dorta G
    Nat Clin Pract Gastroenterol Hepatol; 2006 Aug; 3(8):459-67. PubMed ID: 16883350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma.
    Cheon YK; Lee TY; Lee SM; Yoon JY; Shim CS
    HPB (Oxford); 2012 Mar; 14(3):185-93. PubMed ID: 22321037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma.
    Lee TY; Cheon YK; Shim CS; Cho YD
    World J Gastroenterol; 2012 Oct; 18(39):5589-94. PubMed ID: 23112552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and safety of photodynamic therapy in patients with hilar cholangiocarcinoma: A meta-analysis.
    Chen P; Yang T; Shi P; Shen J; Feng Q; Su J
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102712. PubMed ID: 34995788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy for cholangiocarcinoma.
    Ortner MA
    Lasers Surg Med; 2011 Sep; 43(7):776-80. PubMed ID: 22057505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of ERCP- or PTCS-directed photodynamic therapy for unresectable hilar cholangiocarcinoma.
    Li Z; Jiang X; Xiao H; Chen S; Zhu W; Lu H; Cao L; Xue P; Li H; Zhang D
    Surg Endosc; 2021 Oct; 35(10):5655-5664. PubMed ID: 33104917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment.
    Shim CS; Cheon YK; Cha SW; Bhandari S; Moon JH; Cho YD; Kim YS; Lee LS; Lee MS; Kim BS
    Endoscopy; 2005 May; 37(5):425-33. PubMed ID: 15844020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.
    Nanashima A; Yamaguchi H; Shibasaki S; Ide N; Sawai T; Tsuji T; Hidaka S; Sumida Y; Nakagoe T; Nagayasu T
    J Gastroenterol; 2004 Nov; 39(11):1095-101. PubMed ID: 15580404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for cholangiocarcinoma: overview and new developments.
    Ortner MA
    Curr Opin Gastroenterol; 2009 Sep; 25(5):472-6. PubMed ID: 19550314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma.
    Höblinger A; Gerhardt T; Gonzalez-Carmona MA; Hüneburg R; Sauerbruch T; Schmitz V
    Eur J Med Res; 2011 Sep; 16(9):391-5. PubMed ID: 22024438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.
    Witzigmann H; Berr F; Ringel U; Caca K; Uhlmann D; Schoppmeyer K; Tannapfel A; Wittekind C; Mossner J; Hauss J; Wiedmann M
    Ann Surg; 2006 Aug; 244(2):230-9. PubMed ID: 16858185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.